Kalos Management, Inc. Novartis Ag Transaction History

Kalos Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $276,367 - $334,282	-3,540 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $1,889 - $2,093	-23 Reduced 0.65%	3,540 $299,000
Q2 2020 Aug 13, 2020	BUY	$80.93 - $91.1 $23,469 - $26,419	290 Added 8.86%	3,563 $295,000
Q1 2020 May 13, 2020	SELL	$70.67 - $99.01 $13,285 - $18,613	-188 Reduced 5.43%	3,273 $283,000
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $296,053 - $326,233	3,461 New	3,461 $300,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Kalos Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kalos Management, Inc. with notifications on news.